✦ LIBER ✦

Dose-intensified epirubicin versus standard-dose epirubicin/cyclophosphamide followed by CMF in breast cancer patients with 10 or more positive lymph nodes: Results of a randomised trial (GABG-IV E-93) – The German Adjuvant Breast Cancer Group

✍ Scribed by Wolfgang Eiermann; Erika Graf; Beyhan Ataseven; Bettina Conrad; Jörn Hilfrich; Heidi Massinger-Biebl; Sabine Vescia; Sibylle Loibl; Gunter von Minckwitz; Martin Schumacher; Manfred Kaufmann

Book ID: 116430193
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 665 KB
Volume: 46
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2009.10.001

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PREPARE trial: a randomized phase III tr

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel darbepoetin alfa in primary breast cancer--results at the time of surgery

✍ Untch, M.; Fasching, P. A.; Konecny, G. E.; von Koch, F.; Conrad, U.; Fett, W.; 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 234 KB